James Davies Email

VP Product Development . MicrofluidX

Current Roles

Employees:
35
Revenue:
$0
About
The MicrofluidX technology platform is a revolutionary platform for cell and gene therapy manufacturing. Our key objectives are to reduce production cost by 60-90%, reduce investment costs for new production facilities by 50-70%, enable virtually infinite process scalability through the pre-clinical, clinical and commercial phases of the therapeutic development and increase final product quality and stability.
MicrofluidX Address
Stevenage Bioscience Catalyst
London, London
MicrofluidX Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.